logo
ProjectEnded

EU Patient- cEntric clinicAl tRial pLatform

Ended · Spain, Netherlands, Austria, Belgium, United Kingdom, Italy, Germany, France, Estonia, Switzerland, Sweden, Denmark, Israel, United States, Luxembourg

Source: EU Funding & Tenders Portal

EU-PEARL has the ambition of transforming the current approach of conducting single-compound clinical trials into the use of cross-company Integrated Research Platforms (IRPs), taking into consideration both patients’ interests and the opportunities from novel molecules for addressing medical needs. Patient-centric data and knowledge sharing have the potential to accelerate the development of new

Status
Closed
Sector
Hospital, Electric Vehicles (EVs), Automotive, Education, Government
Location
Spain, Netherlands, Austria, Belgium, United Kingdom, Italy, Germany, France, Estonia, Switzerland, Sweden, Denmark, Israel, United States, Luxembourg
Updated
22 Jul 2026
Source
EU Funding & Tenders Portal

ConstructChat

Ask ConstructChat about EU Patient- cEntric clinicAl tRial pLatform

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

4 Q
The project “EU Patient- cEntric clinicAl tRial pLatform” is an infrastructure initiative in the Hospital sector, located in Spain, Netherlands, Austria, Belgium, United Kingdom, Italy, Germany, France, Estonia, Switzerland, Sweden, Denmark, Israel, United States, Luxembourg. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Participants

Sponsoring Agency

Status

Original status

ended

Taiyo status

Closed

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

EU-PEARL has the ambition of transforming the current approach of conducting single-compound clinical trials into the use of cross-company Integrated Research Platforms (IRPs), taking into consideration both patients’ interests and the opportunities from novel molecules for addressing medical needs. Patient-centric data and knowledge sharing have the potential to accelerate the development of new treatments and reduce the operational costs of clinical trials. EU-PEARL will improve clinical effectiveness, patients’ satisfaction and societal access to timely and affordable medicines and it will shape the clinical trials of the future. This will change the industry paradigm from competition to cooperation in four disease areas and provide the framework for designing IRPs in other disease areas. The main objectives of EU-PEARL are: (1) To create a reusable, accessible and sustainable modular IRP for the design and execution of patient-centric, cross- company IRP in any disease area with unmet needs; (2) To set up the open, dynamic, patient inclusive IRP governance structure that will manage the appropriate regulatory, ethical, legal, statistical and data utilisation requirements of the IRP; (3) To disseminate and exploit the EU-PEARL paradigm through the provision of the necessary common tools, procedures, expertise and operational skills working to the highest scientific, regulatory and ethical standards and best practices, developed jointly by public and industry partners in a consensus-based approach; and (4) To create trial-ready IRP networks in the four disease areas of Major Depressive Disorder (MDD), Tuberculosis (TB), Non-Alcoholic Steatohepatitis (NASH) and Neurofibromatosis (NF).

Location

Country

Spain, Netherlands, Austria, Belgium, United Kingdom, Italy, Germany, France, Estonia, Switzerland, Sweden, Denmark, Israel, United States, Luxembourg

Source

Source

EU Funding & Tenders Portal

URL

More Details

Record type

Project

Sector

Hospital, Electric Vehicles (EVs), Automotive, Education, Government

Article published date

2026-02-01

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project